HEATHLY SUBJECTS
Clinical trials for HEATHLY SUBJECTS explained in plain language.
Never miss a new study
Get alerted when new HEATHLY SUBJECTS trials appear
Sign up with your email to follow new studies for HEATHLY SUBJECTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Meal timing may change how this drug works
Knowledge-focused CompletedThis completed Phase 1 trial studied how taking flonoltinib maleate tablets with or without food changes the drug's levels in the blood. Twenty-four healthy adults aged 18 to 45 took a single 100 mg dose under both fed and fasting conditions. The goal was to understand food's imp…
Matched conditions: HEATHLY SUBJECTS
Phase: PHASE1 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
New drug flonoltinib maleate tested for safety in healthy people
Knowledge-focused CompletedThis early-phase trial tested the safety and how the body processes flonoltinib maleate tablets in 40 healthy adults in China. Participants received a single oral dose of the drug or a placebo, with doses increasing across groups. The study focused on side effects and drug levels…
Matched conditions: HEATHLY SUBJECTS
Phase: PHASE1 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC